• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The growing evidence for targeting P-glycoprotein in lysosomes to overcome resistance.

作者信息

Stefan Sven Marcel, Jansson Patric J, Kalinowski Danuta S, Anjum Rukhsana, Dharmasivam Mahendiran, Richardson Des R

机构信息

Molecular Pharmacology & Pathology Program, Department of Pathology & Bosch Institute, The University of Sydney, Sydney, NSW 2006, Australia.

出版信息

Future Med Chem. 2020 Mar;12(6):473-477. doi: 10.4155/fmc-2019-0350. Epub 2020 Feb 26.

DOI:10.4155/fmc-2019-0350
PMID:32098489
Abstract
摘要

相似文献

1
The growing evidence for targeting P-glycoprotein in lysosomes to overcome resistance.越来越多的证据表明，靶向溶酶体中的P-糖蛋白以克服耐药性。
Future Med Chem. 2020 Mar;12(6):473-477. doi: 10.4155/fmc-2019-0350. Epub 2020 Feb 26.
2
Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes multidrug resistance by a novel mechanism involving the hijacking of lysosomal P-glycoprotein (Pgp).二-2-吡啶基甲酮4,4-二甲基-3-硫代半卡巴腙（Dp44mT）通过一种涉及劫持溶酶体P-糖蛋白（Pgp）的新机制克服多药耐药性。
J Biol Chem. 2015 Apr 10;290(15):9588-603. doi: 10.1074/jbc.M114.631283. Epub 2015 Feb 26.
3
Tumor stressors induce two mechanisms of intracellular P-glycoprotein-mediated resistance that are overcome by lysosomal-targeted thiosemicarbazones.肿瘤应激诱导两种细胞内 P-糖蛋白介导的耐药机制，可被溶酶体靶向硫代卡巴肼克服。
J Biol Chem. 2018 Mar 9;293(10):3562-3587. doi: 10.1074/jbc.M116.772699. Epub 2018 Jan 5.
4
Glucose Modulation Induces Lysosome Formation and Increases Lysosomotropic Drug Sequestration via the P-Glycoprotein Drug Transporter.葡萄糖调节通过P-糖蛋白药物转运体诱导溶酶体形成并增加溶酶体亲和性药物隔离。
J Biol Chem. 2016 Feb 19;291(8):3796-820. doi: 10.1074/jbc.M115.682450. Epub 2015 Nov 24.
5
A mechanism for overcoming P-glycoprotein-mediated drug resistance: novel combination therapy that releases stored doxorubicin from lysosomes via lysosomal permeabilization using Dp44mT or DpC.一种克服P-糖蛋白介导的耐药性的机制：通过使用Dp44mT或DpC使溶酶体通透化，从溶酶体中释放储存的阿霉素的新型联合疗法。
Cell Death Dis. 2016 Dec 1;7(12):e2510. doi: 10.1038/cddis.2016.381.
6
Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.拉帕替尼（泰立沙，GW572016）通过抑制ATP结合盒亚家族B成员1和G成员2的活性来逆转癌细胞中的多药耐药性。
Cancer Res. 2008 Oct 1;68(19):7905-14. doi: 10.1158/0008-5472.CAN-08-0499.
7
Synthesis and biological evaluation of thiophenylbenzofuran derivatives as potential P-glycoprotein inhibitors.硫苯基苯并呋喃衍生物的合成及作为潜在 P-糖蛋白抑制剂的生物评价。
Eur J Med Chem. 2020 Sep 1;201:112422. doi: 10.1016/j.ejmech.2020.112422. Epub 2020 Jun 6.
8
Structure-Activity Relationships of Di-2-pyridylketone, 2-Benzoylpyridine, and 2-Acetylpyridine Thiosemicarbazones for Overcoming Pgp-Mediated Drug Resistance.二-2-吡啶酮、2-苯甲酰吡啶和2-乙酰吡啶硫代氨基脲克服P-糖蛋白介导的耐药性的构效关系
J Med Chem. 2016 Sep 22;59(18):8601-20. doi: 10.1021/acs.jmedchem.6b01050. Epub 2016 Aug 30.
9
Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.海洋海绵来源的齐墩果烷三萜逆转肿瘤细胞 P 糖蛋白（ABCB1）介导的多药耐药性。
Biochem Pharmacol. 2010 Nov 15;80(10):1497-506. doi: 10.1016/j.bcp.2010.08.001. Epub 2010 Aug 7.
10
Sipholenol A, a marine-derived sipholane triterpene, potently reverses P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.西佛醇A是一种源自海洋的西佛烷三萜，能有效逆转P-糖蛋白（ABCB1）介导的癌细胞多药耐药性。
Cancer Sci. 2007 Sep;98(9):1373-80. doi: 10.1111/j.1349-7006.2007.00554.x. Epub 2007 Jul 19.

引用本文的文献

1
LightSpot Fluorescent Conjugates as Highly Efficient Tools for Lysosomal P-gp Quantification in Olaparib-Treated Triple-Negative Breast Cancer Cells.LightSpot荧光偶联物作为奥拉帕利治疗的三阴性乳腺癌细胞中溶酶体P-糖蛋白定量的高效工具。
Int J Mol Sci. 2025 Jul 11;26(14):6675. doi: 10.3390/ijms26146675.
2
Targeting Lysosomes: A Strategy Against Chemoresistance in Cancer.靶向溶酶体：一种克服癌症化疗耐药性的策略。
Mini Rev Med Chem. 2024;24(15):1449-1468. doi: 10.2174/0113895575287242240129120002.
3
Transporter-Mediated Cellular Distribution of Tyrosine Kinase Inhibitors as a Potential Resistance Mechanism in Chronic Myeloid Leukemia.
转运体介导的酪氨酸激酶抑制剂细胞分布作为慢性髓性白血病潜在的耐药机制
Pharmaceutics. 2023 Oct 26;15(11):2535. doi: 10.3390/pharmaceutics15112535.
4
Teaching an old dog new tricks: reactivated developmental signaling pathways regulate ABCB1 and chemoresistance in cancer.老狗学新招：重新激活的发育信号通路调控癌症中的ABCB1及化疗耐药性
Cancer Drug Resist. 2021 Jun 19;4(2):424-452. doi: 10.20517/cdr.2020.114. eCollection 2021.
5
Is P-Glycoprotein Functionally Expressed in the Limiting Membrane of Endolysosomes? A Biochemical and Ultrastructural Study in the Rat Liver.P-糖蛋白在内涵体溶酶体的限制膜上是否有功能表达？大鼠肝的生化和超微结构研究。
Cells. 2022 May 5;11(9):1556. doi: 10.3390/cells11091556.
6
Strategies to gain novel Alzheimer's disease diagnostics and therapeutics using modulators of ABCA transporters.利用ABCA转运蛋白调节剂获取新型阿尔茨海默病诊断方法和治疗手段的策略。
Free Neuropathol. 2021;2:33. doi: 10.17879/freeneuropathology-2021-3528. Epub 2021 Dec 13.
7
Binding mode analysis of ABCA7 for the prediction of novel Alzheimer's disease therapeutics.用于预测新型阿尔茨海默病治疗药物的ABCA7结合模式分析
Comput Struct Biotechnol J. 2021 Nov 27;19:6490-6504. doi: 10.1016/j.csbj.2021.11.035. eCollection 2021.
8
Similarities and differences in the localization, trafficking, and function of P-glycoprotein in MDR1-EGFP-transduced rat versus human brain capillary endothelial cell lines.多药耐药 1 型-EGFP 转染大鼠与人脑微血管内皮细胞系中 P-糖蛋白的定位、转运和功能的相似性和差异。
Fluids Barriers CNS. 2021 Aug 3;18(1):36. doi: 10.1186/s12987-021-00266-z.
9
Novel Intrinsic Mechanisms of Active Drug Extrusion at the Blood-Brain Barrier: Potential Targets for Enhancing Drug Delivery to the Brain?血脑屏障处活性药物外排的新型内在机制：增强药物脑内递送的潜在靶点？
Pharmaceutics. 2020 Oct 14;12(10):966. doi: 10.3390/pharmaceutics12100966.